Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: World J Urol

Search In Journal Title:

Abbravation: World Journal of Urology

Search In Journal Abbravation:

Publisher

Springer-Verlag

Search In Publisher:

DOI

10.1006/bbrc.2001.5248

Search In DOI:

ISSN

1433-8726

Search In ISSN:
Search In Title Of Papers:

Adverse effects of drug therapies on male and fema

Authors: Th Stadler M Bader S Ückert M Staehler A Becker C G Stief
Publish Date: 2006/11/08
Volume: 24, Issue: 6, Pages: 623-629
PDF Link

Abstract

Sexual dysfunctions SD are adverse effects of common drug therapies that have rarely been considered in investigations so far Possibly it is barely known that many widespread and frequently prescribed medications and drug therapies can have significant impact on vascular and nerval processes as well as on endocrinologic and psychoneuroendocrinologic systems and therefore can influence sexual functions Impotence and disorders of the erectile function can mainly be caused by antidopaminergic mechanisms whereas ejaculatory disorders and anorgasmia often can be explained by antiserotoninergic effects Anticholinergic and adrenoloytic agents can also cause a particular impairment of erectile functions The following considerations will show that the detection and treatment of SD also in women should be given much more attention since druginduced SDs occur predominantly in indications where a SD itself can be a symptom of the disease


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer
  2. Treatment of pediatric urolithiasis: how small is “small enough”?
  3. The effect of a cyclic uniaxial strain on urinary bladder cells
  4. The value of the preoperative 1-h pad test with pessary insertion for predicting the need for a mid-urethral sling following pelvic prolapse surgery: a cohort study
  5. Minimally invasive treatment of renal transplant nephrolithiasis
  6. Improved performance of SPECT-CT In-111 capromab pendetide by correlation with diffusion-weighted magnetic resonance imaging for identifying metastatic pelvic lymphadenopathy in prostate cancer
  7. Which factors affect the hospital re-admission and re-hospitalization after flexible ureterorenoscopy for kidney stone?
  8. The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients
  9. Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria
  10. Is multichannel urodynamic assessment necessary before considering a surgical treatment of BPH? Pros and cons
  11. Complications of laparoscopic pyeloplasty
  12. Influence of age on false positive rates of urine-based tumor markers
  13. Phosphodiesterase type 2 distribution in the guinea pig urinary bladder
  14. Changing concepts in the surgery of renal cell carcinoma
  15. Association of polymorphisms in CYP19A1 and CYP3A4 genes with lower urinary tract symptoms, prostate volume, uroflow and PSA in a population-based sample
  16. Reduction in incidence of lymphocele following extraperitoneal radical prostatectomy and pelvic lymph node dissection by bilateral peritoneal fenestration
  17. Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPAN
  18. How accurate are present risk group assignment tools in penile cancer?
  19. Comparison of retrograde intrarenal surgery, shockwave lithotripsy, and percutaneous nephrolithotomy for treatment of medium-sized radiolucent renal stones
  20. German urologists under national socialism
  21. OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results
  22. Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia
  23. Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia
  24. Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis
  25. The influence of obstructive interval on patency rates following microsurgical epididymovasostomy
  26. The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
  27. 3D Navigo™ versus TRUS-guided prostate biopsy in prostate cancer detection
  28. 3D Navigo™ versus TRUS-guided prostate biopsy in prostate cancer detection
  29. Correlation of endorectal coil magnetic resonance imaging of the prostate with pathologic stage
  30. Impact of dutasteride on nocturia in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): a pooled analysis of three phase III studies
  31. Significance of preoperative PSA velocity in men with low serum PSA and normal DRE
  32. Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study
  33. Adult inguinoscrotal sarcomas: outcome analysis of 21 cases, systematic review of the literature and meta-analysis
  34. Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival
  35. Evaluation of complications in endoscopic extraperitoneal radical prostatectomy in a modular training programme: a multicentre experience
  36. Health care reform in 2010: transforming the delivery system to improve quality of care
  37. A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms
  38. Robotic kidney transplantation: one year after the beginning
  39. The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study
  40. Clinical outcomes and nadir prostate-specific antigen (PSA) according to initial PSA levels in primary androgen deprivation therapy for metastatic prostate cancer
  41. Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy
  42. Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series
  43. Preoperative sex steroids are significant predictors of early biochemical recurrence after radical prostatectomy
  44. Androgens and prostate cancer

Search Result: